Also, from the Annual 2018, P51 to 55 documents the commercial opportunity.
1. Acute Graft Versus Host Disease -Â
According to the Center for International Blood and Marrow Transplant Research, there are approximately 30,000 allogeneic BMTs globally per year for diseases including hematological cancers, with ~20% of all cases in the pediatric population. Nearly 50% of all allogeneic BMT patients develop aGVHD. Liver or gastrointestinal involvement occur in up to 40% of all patients with aGVHD and are associated with the greatest risk of death, with mortality rates of up to 85%.
2. Moderate-advance and end-stage heart failure with LVAD -
In 2016, more than 15 million patients in the seven major global pharmaceutical markets are estimated to have been diagnosed with CHF. The American Heart Association estimated in 2017 that prevalence is expected to grow 46% by 2030 in the U.S., affecting more than 8 million Americans. CHF causes severe economic, social, and personal costs. In the U.S., it is estimated that CHF results in direct costs of $60.2 billion annually when identified as a primary diagnosis and $115.0 billion as part of a disease milieu.
3. Chronic Low Back Pain -
In 2016, over 7 million people in the U.S. alone were estimated to suffer from CLBP caused by DDD, of which 3.2 million patients have moderate disease. After failure of conservative measures (medication, injections, epidural steroid physical therapy etc.), there is a need for treatments that both reduce pain and improve function over a sustained period of time. When disc degeneration has progressed to a point that pain and loss of function can no longer be managed by conservative means, major invasive surgery such as spinal fusion is the most commonly offered option.
- Forums
- ASX - By Stock
- MSB
- Potential Market Size for Mesoblast products in US
Potential Market Size for Mesoblast products in US, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
98.5¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.138B |
Open | High | Low | Value | Volume |
99.0¢ | $1.03 | 97.5¢ | $2.273M | 2.282M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 98.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 74986 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 40180 | 0.980 |
13 | 78821 | 0.975 |
10 | 204336 | 0.970 |
7 | 88276 | 0.965 |
10 | 356512 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
0.985 | 17504 | 7 |
0.990 | 71355 | 20 |
0.995 | 31446 | 8 |
1.000 | 40656 | 6 |
1.005 | 42825 | 5 |
Last trade - 15.44pm 05/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |